Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMonitise Regulatory News (MONI)

  • There is currently no data for MONI

Form 8.3 - Monitise PLC

30 Jan 2015 14:46

RNS Number : 6527D
Legg Mason, Inc.
30 January 2015
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Legg Mason, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

LMM, LLC

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Monitise PLC

GB00B1YMRB82

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

22/01/15

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES/NO - NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

66,058,475

3.09%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

66,058,475

3.09%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

NO

 

 

Date of disclosure:

30/01/15

Contact name:

Shirley A. Hinton

Telephone number:

+1 410.454.5632

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEALFEDLLSEFF
Date   Source Headline
8th Jun 20179:00 amRNSBlock listing Return
1st Jun 20179:00 amRNSTotal Voting Rights
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20178:31 amRNSHolding(s) in Company
3rd Apr 20179:00 amRNSTotal Voting Rights
1st Mar 20179:00 amRNSTotal Voting Rights
24th Feb 20177:00 amRNSIssue of Deferred Consideration
23rd Feb 20177:00 amRNSHalf-year Report
1st Feb 20179:22 amRNSTotal Voting Rights
12th Jan 201711:24 amRNSNotice of Results
3rd Jan 201711:56 amRNSStatement re Monitise Americas
3rd Jan 20179:00 amRNSTotal Voting Rights
30th Dec 201612:35 pmRNSPrice Monitoring Extension
28th Dec 20169:59 amRNSBlock listing Return
8th Dec 20169:00 amRNSBlock listing Return
1st Dec 20168:59 amRNSTotal Voting Rights
24th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20169:39 amRNSTotal Voting Rights
19th Oct 20161:09 pmRNSResult of AGM
14th Oct 20163:46 pmRNSHolding(s) in Company
3rd Oct 20169:00 amRNSTotal Voting Rights
20th Sep 20169:00 amRNSAnnual Report & Accounts and Notice of AGM
8th Sep 20167:00 amRNSFY 2016 Results
7th Sep 20164:53 pmRNSChange of Registered Office
1st Sep 20166:24 pmRNSTotal Voting Rights
21st Jul 20167:00 amRNSTrading Update
7th Jul 20164:38 pmRNSHolding(s) in Company
7th Jul 20161:07 pmRNSIssue of Deferred Consideration
1st Jul 20164:45 pmRNSTotal Voting Rights
30th Jun 20166:25 pmRNSDirectorate Change
27th Jun 20169:00 amRNSBlock Listing Return
24th Jun 201612:08 pmRNSSecond Price Monitoring Extn
24th Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 201612:07 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
15th Jun 201612:07 pmRNSSecond Price Monitoring Extn
15th Jun 201612:02 pmRNSPrice Monitoring Extension
14th Jun 201612:07 pmRNSSecond Price Monitoring Extn
14th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20169:00 amRNSBlock Listing Return
1st Jun 20164:40 pmRNSSecond Price Monitoring Extn
1st Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20169:00 amRNSTotal Voting Rights
31st May 20167:00 amRNSStatement re Monitise Content
3rd May 20169:00 amRNSTotal Voting Rights
1st Apr 20169:00 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAppointment of COO
17th Mar 20164:13 pmRNSIssue of earn-out consideration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.